GlassScriptPhysician profile
Casey Kafena
NPI 1811537301
$1,765.57
in general payments reported to CMS, 2019-2025
21 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $439 · 2023: $339 · 2024: $399 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $352.19 | 2021-2024 | Amvuttra, Onpattro |
| Argenx US, INC. | $291.44 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Genentech USA, INC. | $125.69 | 2022 | |
| Grt US Holding, INC. | $119.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $115.36 | 2024 | Wainua |
| Amylyx Pharmaceuticals, INC. | $111.42 | 2023-2024 | Relyvrio |
| Spark Therapeutics, INC. | $96.19 | 2021 | |
| Bridgebio Pharma, INC. | $93.16 | 2025 | Attruby |
| Ucb, INC. | $58.96 | 2023-2024 | Zilbrysq |
| Tanabe Pharma America, INC. | $52.50 | 2022-2023 | |
| Merz Pharmaceuticals, LLC | $50.10 | 2022 | |
| Amicus Therapeutics, INC. | $47.56 | 2024-2025 | Opfolda, Pombiliti |
| Medtronic, INC. | $46.92 | 2022-2025 | Percept PC Brainsense |
| Genzyme Corporation | $38.81 | 2021 | |
| Abbvie INC. | $36.98 | 2023-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $31.61 | 2021-2022 | |
| Grifols USA, LLC | $22.15 | 2023 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $21.01 | 2022 | |
| Octapharma USA, INC. | $20.00 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.88 | 2021 | |
| Lundbeck LLC | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Kafena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.